Q3 2022 13F Holders as of 9/30/2022
-
Type / Class
-
Equity / Common Stock, $0.00001 par value per share
-
Shares outstanding
-
75.5M
-
Number of holders
-
1
-
Total 13F shares, excl. options
-
5
-
Shares change
-
-3.71M
-
Total reported value, excl. options
-
$1K
-
Value change
-
-$1.5M
-
Number of sells
-
-22
-
Price
-
$200.00
Significant Holders of Cellectar Biosciences, Inc. - Common Stock, $0.00001 par value per share (CLRB) as of Q3 2022
23 filings reported holding CLRB - Cellectar Biosciences, Inc. - Common Stock, $0.00001 par value per share as of Q3 2022.
Cellectar Biosciences, Inc. - Common Stock, $0.00001 par value per share (CLRB) has 1 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 5 shares
of 75.5M outstanding shares and own 0% of the company stock.
Largest 10 shareholders include IFP Advisors, Inc (5 shares), GEODE CAPITAL MANAGEMENT, LLC (0 shares), STATE STREET CORP (0 shares), US BANCORP \DE\ (0 shares), COMMONWEALTH EQUITY SERVICES, LLC (0 shares), NORTHERN TRUST CORP (0 shares), VANGUARD GROUP INC (0 shares), COMMERCE BANK (0 shares), RENAISSANCE TECHNOLOGIES LLC (0 shares), and FRANKLIN RESOURCES INC (0 shares).
This table shows the top 1 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.